Abstract:Secondary lymphoid tissue chemokine (SLC) is a CC chemokine that plays an important role in leukocytes homing to lymphoid tissues. The ability of SLC to co-localize both T cells and dendritic cells formed the rationale to evaluate its utility in cancer immunotherapy. The in vivo antitumor effect of murine SLC (mSLC) has been well documented, but little is known about that of human SLC (hSLC). To investigate the antitumor efficiency in vivo of hSLC, the hSLC gene was artificially synthesized and induced to express as a soluble form in Escherichia coli. After purification, the purity of the recombinant human SLC (rhSLC) protein was above 95% by SDS-PAGE analysis. The K(d) of rhSLC binding to peripheral blood lymphocytes (PBLs) was 0.2186 +/- 0.02675 microM as assessed by FACS, and the maximal chemotactic index of rhSLC was 9.49 at 100 nM as assessed by in vitro chemotaxis assay. Then genomic sequences of hSLC and mSLC, and of human CCR7 (hCCR7) and murine CCR7 (mCCR7), the receptor for SLC, were aligned. It was found that hSLC and mSLC share 70.72% identity and hCCR7 and mCCR7share 86.77% identity. Furthermore, we found that rhSLC could chemoattract murine peripheral blood mononuclear cells (PBMCs) in vitro. On the basis of these facts, immune competent mice inoculated with S180 sarcoma cells were chosen as an in vivo model. Intratumoral injections of rhSLC inhibited tumor growth and increased survival. These findings suggest that, despite its incapability to bind to either human or murine CXCR3, which is related to angiostasis, rhSLC can induce an antitumor response in vivo by another route. This report proves that rhSLC has a potent tumor-inhibition ability that makes it a promising candidate agent in cancer immunotherapy.

[Construction of Eukaryotic Expression Vector of Murine SLC Gene and Characterization of Its Chemotactic Function].

Construction of the expression vector pVAX1-mSLC and its expression in COS-7 cells

[Cloning and Expression in Escherichia Coli of Secondary Lymphoid-Tissue Chemokine (SLC) Gene].

CLONING,EUKARYOTIC EXPRESSION AND EXPRESSION PATTERN OF SPHINGOMYELIN SYNTHASE-RELATED GENE(CsSMSr) FROM Chilo Suppressalis(WALKER)

TO CONSTRUCT A RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR CARRYING THE GENE ENCODING THE MATURE PEPTIDE OF SECONDARY LYMPHOID-TISSUE CHEMOKINE

Construction and Identification of a Recombinant Attenuated Salmonella Expressing Streptococcus suis sly Gene

[Expression and Purification of Mouse B Lymphocyte Chemoattractant].

Construction of Eukaryotic Expression Vector for Human CCL21 and Characterization of Its Chemotactic Activity

[Construction of Eukaryotic Expression Vector of Murine Chemokine (C-C Motif) Receptor 2 (ccr2) and Establishment of Its Stably Transfected RAW264.7 Cell Line].

[Expression and identification of recombinant mouse gene B7-H4].

Construction of eukaryotic expression vector of rat HAS-3 gene and its effects on chemotaxis]

Soluble Expression of Recombinant Human Secondary Lymphoid Chemokine (SLC) in E. Coli and Research on Its in Vitro and in Vivo Bioactivity.

Construction of recombined murine CD40 ligand cDNA eukaryotic expression vector

[Construction of eukaryotic expression plasmid pSecTag2B-msBlyS expressing mouse soluble B lymphocyte stimulator].

Construction and direct immunization of eukaryotic expression plasmid encoding human soluble B lymphocyte stimulator.

Construction and Identification of Eukaryotic Expression Vector Bearing Mouse Ghrelin Receptor

[Expression and Cloning of Mcd99l2 Gene from Mouse B Lymphoma Cell Line A20 and Construction of Its Eukaryotic Expression Vector].

Construction of Eukaryotic Expression Vector Containing Mouse IL-18 and Examination of the Bioactivity of the Expressed IL-18

Construction and Identification of Eukarytic Express Plasmid of Murine IL-2

[Construction of Mouse VCAM-1 Expression Vector and Establishment of Stably Transfected MSC Line C3H10T1/2].

[Construction of Expression Vector Plck-Cd69-ires-egfp and Generation of CD69 Transgenic Mice].